Analysis of perforin expression in peripheral blood and lesions in severe and mild psoriasis

Journal of Dermatological Science

Volumn 47, Issue 1, 2007, Pages 29-36

  Prpić Massari, Larisa ^a   Kaštelan, Marija ^a   Laškarin, Gordana ^b   Zamolo, Gordana ^b   Massari, Dražen ^c   Rukavina, Daniel ^b  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c NONE   (Croatia)

Author keywords

Apoptosis; Cytotoxic T lymphocytes; Natural killer cells; Perforin; Psoriasis

Indexed keywords

CD56 ANTIGEN; CD8 ANTIGEN; PERFORIN;

ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NATURAL KILLER T CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSORIASIS; SKIN DEFECT;

ADULT; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PORE FORMING CYTOTOXIC PROTEINS; PSORIASIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 34249103136     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.02.007     Document Type: Article

References (32)

1. Kirby B., and Griffiths C.E.M. Psoriasis: the future. Br J Dermatol 144 (2001) 37-43
2. Krueger J.G. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 46 (2002) 1-23
3. Krueger J.G., Krane J.F., Carter D.M., and Gottlieb A.B. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 94 (1990) 135S-140S
4. Ortonne J.P. Recent developments in the understanding of the pathogenesis of psoriasis. Br J Dermatol 140 (1999) 1-7
5. Bovenschen H.J., Seyger M.M., and Van de Kerkhof P.C. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation. Br J Dermatol 153 (2005) 72-78
6. Paukkonen K., Naukkarinen A., and Horsmanheimo M. The development of manifest psoriatic lesions is linked with the invasion of CD8+ T cells and CD11c+ macrophages into the epidermis. Arch Dermatol Res 284 (1992) 375-379
7. Saikumar P., Dong Z., Mikhailov V., et al. Apoptosis: definition, mechanisms, and relevance to disease. Am J Med 107 (1999) 489-506
8. Prpic L., Strbo N., Sotosek V., et al. Assessment of perforin expression in peripheral blood lymphocytes in psoriatic patients during exacerbation of disease. Acta Derm Venereol 211 (2000) 14-16
9. Kaštelan M., Prpić Massari L., Gruber F., et al. Perforin expression is up-regulated in the epidermis of psoriatic lesions. Br J Dermatol 151 (2004) 831-836
10. Behrendt C., Gollnick H., and Bonnekoh B. Up-regulated perforin expression of CD8+ blood lymphocytes in generalized non-anaphylactic drug eruptions and exacerbated psoriasis. Eur J Dermatol 10 (2000) 365-369
11. Yawalkar N., Schmid S., Braathen L.R., and Pichler W.J. Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis. Br J Dermatol 144 (2001) 1133-1139
12. Yawalkar N., Hunger R.E., Burl C., et al. A comparative study of the expression of cytotoxic proteins in allergic contact dermatitis and psoriasis. Am J Pathol 158 (2001) 803-808
13. Schmitt J., and Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 210 (2005) 194-199
14. Rukavina D., Balen-Marunic S., Rubesa G., et al. Perforin expression in peripheral blood lymphocytes in rejecting and tolerating kidney transplant recipients. Transplantation 61 (1996) 285-291
15. Bos J.D., and De Rie M.A. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 20 (1999) 40-46
16. Nickoloff B.J., and Nestle F.O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 113 (2004) 1664-1675
17. Andersen M.H., Schrama D., Thor Straten P., and Becker J.C. Cytotoxic T cells. J Invest Dermatol 12 (2006) 32-41
18. McCall C., and Cohen J.J. Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease. J Invest Dermatol 97 (1991) 11-114
19. Ashton-Rickardt P.G. The granule pathway of programmed cell death. Crit Rev Immunol 25 (2005) 161-182
20. Rubins A.Y., and Merson A.G. Subpopulations of T lymphocytes in psoriasis patients and their changes during immunotherapy. J Am Acad Dermatol 17 (1987) 972-977
21. Baker B.S., Swain A.F., Valdimarsson H., and Fry L. T cell subpopulations in the blood and skin of patients with psoriasis. Br J Dermatol 110 (1984) 37-44
22. Baker B.S., Swain A.F., Fry L., and Valdimarsson H. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 110 (1984) 555-564
23. Teraki Y., Miyake A., Takebayashi R., and Shiohara T. Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris. Clin Exp Dermatol 29 (2004) 658-663
24. De Boer O.J., Wakelkamp I.M.M.J., Pals S.T., et al. Increased expression of adhesion receptors in both lesional and non-lesional skin. Arch Dermatol Res 286 (1994) 304-311
25. Rossiter H., Van Reijsen F., Mudde G.C., et al. Skin disease-related T cell bind to endothelial selectins: expressions of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding. Eur J Immunol 24 (1994) 205-210
26. Podack E.R. Functional significance of two cytolytic pathways of cytotoxic T lymphocytes. J Leukoc Biol 57 (1995) 548-552
27. Williams A., Peh C.A., and Elliott T. The cell biology of MHC class I antigen presentation. Tissue Antigens 59 (2002) 3-17
28. Nickoloff B.J. The immunologic and genetic basis of psoriasis. Arch Dermatol 135 (1999) 1104-1110
29. Takahashi H., Manabe A., Ishida-Yamamoto A., et al. Aberrant expression of apoptosis-related molecules in psoriatic epidermis. J Dermatol Sci 28 (2002) 187-197
30. Tomokova H., Fujimoto W., and Arata J. Expression of the bcl-2 homologue bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers. Eur J Dermatol 8 (1998) 256-260
31. Cameron A.L., Kirby B., and Griffiths C.E. Circulating natural killer cells in psoriasis. Br J Dermatol 149 (2003) 160-164
32. Bos J.D., Hulsebosch H.J., Krieg S.R., et al. Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res 275 (1983) 181-189